Also, it has been documented that the administration of FABP4 externally induces endoplasmic reticulum stress in HepG2 liver cells which can potentially establish a connection between hepatic insulin resistance and metabolic dysfunction associated with obesity [37]. Here, FABP4 is linked to Insulin resistance.